Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors

作者: Kevin R. Condroski , Timothy Kercher , Jeongbeob Seo , Steven W. Andrews , Shelley Allen

DOI:

关键词:

摘要: Compounds of Formula I: or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates prodrugs thereof, where R1, R2, Ra, Rb, Rc, Rd, X, Y, B, and Ring C are as defined herein, wherein the Y-B moiety NH-C(=X)-NH in trans configuration, inhibitors TrkA kinase useful treatment diseases which can be treated with a inhibitor such pain, cancer, inflammation, neurodegenerative certain infectious diseases.

参考文章(22)
James Ralph Hanson, Protecting Groups in Organic Synthesis ,(1999)
Howard C. Ansel, Loyd V. Allen, Nicholas G. Popovich, Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems ,(2004)
Tony Michael Raynham, Emma Jane Welsh, Antony William Oliver, John Jamieson Caldwell, Ian Collins, Cornelius Albertus Johannes Matijssen, Therapeutic oxy-phenyl-aryl compounds and their use ,(2008)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Suresh Kumar Kizhakkethil-George, Craig A. Leach, Benjamin Nicholson, Ping Cao, Joseph Weinstock, William D. Kingsbury, Anti-neoplastic compounds, compositions and methods ,(2010)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Dean A. Wacker, Douglas G. Batt, James R. Pruitt, Soo S. Ko, N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity ,(2001)
Anja Limberg, Caterina Bissantz, Claus Riemer, Philippe Jablonski, Henner Knust, Andreas Koblet, Hasane Ratni, Matthias Nettekoven, Pyrrolidine derivatives as nk2 receptor antagonists ,(2009)
Kevin Ronald Condroski, Timothy Kercher, Shelley Allen, Steven Wade Andrews, Yutong Jiang, Lily Huang, Julia Haas, Jeongbeob Seo, Substituted Pyrazolo [1,5-A] Pyrimidine Compounds as TRK Kinase Inhibitors ,(2009)